The neohesperidine dc market is projected to grow from USD 661.1 million in 2025 to USD 1184.0 million by 2035, at a CAGR of 6.0%. Food And Beverage will dominate with a 34.5% market share, while sweetener will lead the application segment with a 61.0% share.